Aljurf MD - Search Results

1

Antigen- and/or immune-driven lymphoproliferative disorders.

Aljurf MD, Owaidah TW, Ezzat A, Ibrahim E, Tbakhi A. Aljurf MD, et al. Ann Oncol. 2003 Nov;14(11):1595-606. doi: 10.1093/annonc/mdg442. Ann Oncol. 2003. PMID: 14581266 Free article. Review. No abstract available.

2

Emerging role of gammadelta T-cells in health and disease.

Aljurf M, Ezzat A, O Musa M. Aljurf M, et al. Blood Rev. 2002 Dec;16(4):203-6. doi: 10.1016/s0268-960x(02)00029-2. Blood Rev. 2002. PMID: 12350363 Review.

3

Current advances, problems and prospects for vaccine-based immunotherapy in follicular non-Hodgkin's lymphoma.

Dermime S, Aljurf MD. Dermime S, et al. Among authors: aljurf md. Leuk Lymphoma. 2005 Apr;46(4):497-507. doi: 10.1080/104281904000025104. Leuk Lymphoma. 2005. PMID: 16019477 Review.

4

Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection.

Algassim AA, Elghazaly AA, Alnahdi AS, Mohammed-Rahim OM, Alanazi AG, Aldhuwayhi NA, Alanazi MM, Almutairi MF, Aldeailej IM, Kamli NA, Aljurf MD. Algassim AA, et al. Among authors: aljurf md. Ann Hematol. 2021 Jan;100(1):37-43. doi: 10.1007/s00277-020-04256-3. Epub 2020 Sep 12. Ann Hematol. 2021. PMID: 32918594 Free PMC article.

5

Next-Generation Chimeric Antigen Receptor T-cells.

Yi D, Gergis M, Hsu J, Yang Y, Bi X, Aljurf M, Gergis U. Yi D, et al. Hematol Oncol Stem Cell Ther. 2022 Dec 15;15(3):117-121. doi: 10.56875/2589-0646.1035. Hematol Oncol Stem Cell Ther. 2022. PMID: 36537905 Free article. Review.

6

Infectious Complications and Preventative Strategies following Chimeric Antigen Receptor T-cells (CAR-T cells) Therapy for B-Cell Malignancies.

Haroon A, Muhsen IN, Abid MB, Albabtain A, Alahmari A, Ahmed SO, Fakih RE, Aljurf M. Haroon A, et al. Hematol Oncol Stem Cell Ther. 2022 Nov 25;15(3):153-158. doi: 10.56875/2589-0646.1049. Hematol Oncol Stem Cell Ther. 2022. PMID: 36633965 Free article. Review.

7

The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes.

Nassani M, Fakih RE, Passweg J, Cesaro S, Alzahrani H, Alahmari A, Bonfim C, Iftikhar R, Albeihany A, Halkes C, Ahmed SO, Dufour C, Aljurf M. Nassani M, et al. Front Oncol. 2023 May 8;13:1135160. doi: 10.3389/fonc.2023.1135160. eCollection 2023. Front Oncol. 2023. PMID: 37223686 Free PMC article. Review.

8

A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL.

Alyamany R, El Fakih R, Alnughmush A, Albabtain A, Kharfan-Dabaja MA, Aljurf M. Alyamany R, et al. Front Oncol. 2024 Mar 21;14:1301979. doi: 10.3389/fonc.2024.1301979. eCollection 2024. Front Oncol. 2024. PMID: 38577334 Free PMC article. Review.

9

Revisiting intrathecal thiotepa: Efficacy and safety in secondary CNS malignancies.

Jamison T, Haque E, Muhsen IN, Samarkandi H, Fakih RE, Aljurf M. Jamison T, et al. Med Oncol. 2024 Jun 17;41(7):177. doi: 10.1007/s12032-024-02401-w. Med Oncol. 2024. PMID: 38884819 Review.

10

The evolving role of monoclonal antibodies and dendritic cell therapy in hematologic malignancies.

Owaidah TM, Aljurf MD. Owaidah TM, et al. Among authors: aljurf md. Hematology. 2002 Oct;7(5):265-72. doi: 10.1080/1024533021000037180. Hematology. 2002. PMID: 12850813 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters